Saturday, January 24, 2026 | 08:57 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Glenmark Pharmaceuticals gets final approval for Tretinoin Capsules

Capital Market

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (USFDA) for Tretinoin Capsules, 10 mg, the generic version of Vesanoid Capsules, 10 mg, of Hoffmann La Roche, Inc. (which is no longer being marketed in the United States).

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 27 2016 | 9:19 AM IST

Explore News